CONDENSED STATEMENTS OF CASH FLOWS (USD $)	6 Months Ended
	Sep. 30, 2011	Sep. 30, 2010
Cash flows from operating activities:
Net income (loss)	$ (4,614,529)	$ (5,323,756)
Adjustments to reconcile net income(loss) to net cash (used in) provided by operating activities
Amortization	488,268	893,177
Distributions from Operating Partnerships	224,978	133,025
Share of (Income) Loss from Operating Partnerships	937,012	1,292,228
Changes in assets and liabilities
(Decrease) Increase in accounts payable and accrued expenses	(69,386)	109,850
Decrease (Increase) in other assets	(66,751)	(184,673)
(Decrease) Increase in accounts payable affiliates	2,289,068	1,577,702
Net cash (used in) provided by operating activities	(811,340)	(1,502,447)
Cash flows from investing activities:
Capital contributions paid to Operating Partnerships	0	(111,584)
Proceeds from the disposition of Operating Partnerships	1,260,372	2,829,398
Net cash (used in) provided by investing activities	1,260,372	2,717,814
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS	449,032	1,215,367
Cash and cash equivalents, beginning	7,926,372	6,498,869
Cash and cash equivalents, ending	8,375,404	7,714,236
Supplemental schedule of noncash investing and financing activities:
The Fund applied notes receivable and advances to its capital contribution obligation to operating limited partnerships.	12,841	369,625
Series Twenty
Cash flows from operating activities:
Net income (loss)	(35,711)	881,946
Adjustments to reconcile net income(loss) to net cash (used in) provided by operating activities
Amortization	0	0
Distributions from Operating Partnerships	0	0
Share of (Income) Loss from Operating Partnerships	(88,000)	(921,489)
Changes in assets and liabilities
(Decrease) Increase in accounts payable and accrued expenses	2,124	34,076
Decrease (Increase) in other assets	0	2,633
(Decrease) Increase in accounts payable affiliates	98,514	(842,239)
Net cash (used in) provided by operating activities	(23,073)	(845,073)
Cash flows from investing activities:
Capital contributions paid to Operating Partnerships	0	0
Proceeds from the disposition of Operating Partnerships	88,000	921,489
Net cash (used in) provided by investing activities	88,000	921,489
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS	64,927	76,416
Cash and cash equivalents, beginning	245,496	187,333
Cash and cash equivalents, ending	310,423	263,749
Supplemental schedule of noncash investing and financing activities:
The Fund applied notes receivable and advances to its capital contribution obligation to operating limited partnerships.	0	0
Series Twenty One
Cash flows from operating activities:
Net income (loss)	(63,882)	(80,832)
Adjustments to reconcile net income(loss) to net cash (used in) provided by operating activities
Amortization	0	0
Distributions from Operating Partnerships	0	0
Share of (Income) Loss from Operating Partnerships	0	0
Changes in assets and liabilities
(Decrease) Increase in accounts payable and accrued expenses	0	0
Decrease (Increase) in other assets	0	0
(Decrease) Increase in accounts payable affiliates	(105,039)	13,000
Net cash (used in) provided by operating activities	(168,921)	(67,832)
Cash flows from investing activities:
Capital contributions paid to Operating Partnerships	0	0
Proceeds from the disposition of Operating Partnerships	0	0
Net cash (used in) provided by investing activities	0	0
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS	(168,921)	(67,832)
Cash and cash equivalents, beginning	338,841	287,156
Cash and cash equivalents, ending	169,920	219,324
Supplemental schedule of noncash investing and financing activities:
The Fund applied notes receivable and advances to its capital contribution obligation to operating limited partnerships.	0	0
Series Twenty Two
Cash flows from operating activities:
Net income (loss)	(112,305)	631,950
Adjustments to reconcile net income(loss) to net cash (used in) provided by operating activities
Amortization	0	0
Distributions from Operating Partnerships	0	0
Share of (Income) Loss from Operating Partnerships	0	(738,514)
Changes in assets and liabilities
(Decrease) Increase in accounts payable and accrued expenses	(7,500)	10,950
Decrease (Increase) in other assets	0	2,500
(Decrease) Increase in accounts payable affiliates	(55,563)	108,576
Net cash (used in) provided by operating activities	(175,368)	15,462
Cash flows from investing activities:
Capital contributions paid to Operating Partnerships	0	0
Proceeds from the disposition of Operating Partnerships	0	738,514
Net cash (used in) provided by investing activities	0	738,514
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS	(175,368)	753,976
Cash and cash equivalents, beginning	344,376	150,885
Cash and cash equivalents, ending	169,008	904,861
Supplemental schedule of noncash investing and financing activities:
The Fund applied notes receivable and advances to its capital contribution obligation to operating limited partnerships.	0	0
Series Twenty Three
Cash flows from operating activities:
Net income (loss)	(115,504)	575,982
Adjustments to reconcile net income(loss) to net cash (used in) provided by operating activities
Amortization	0	0
Distributions from Operating Partnerships	0	0
Share of (Income) Loss from Operating Partnerships	0	(668,669)
Changes in assets and liabilities
(Decrease) Increase in accounts payable and accrued expenses	(7,500)	25,900
Decrease (Increase) in other assets	0	0
(Decrease) Increase in accounts payable affiliates	(83,162)	93,956
Net cash (used in) provided by operating activities	(206,166)	27,169
Cash flows from investing activities:
Capital contributions paid to Operating Partnerships	0	0
Proceeds from the disposition of Operating Partnerships	0	668,669
Net cash (used in) provided by investing activities	0	668,669
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS	(206,166)	695,838
Cash and cash equivalents, beginning	325,579	96,567
Cash and cash equivalents, ending	119,413	792,405
Supplemental schedule of noncash investing and financing activities:
The Fund applied notes receivable and advances to its capital contribution obligation to operating limited partnerships.	0	0
Series Twenty Four
Cash flows from operating activities:
Net income (loss)	22,558	(35,688)
Adjustments to reconcile net income(loss) to net cash (used in) provided by operating activities
Amortization	0	0
Distributions from Operating Partnerships	0	0
Share of (Income) Loss from Operating Partnerships	(107,131)	0
Changes in assets and liabilities
(Decrease) Increase in accounts payable and accrued expenses	(4,578)	0
Decrease (Increase) in other assets	0	0
(Decrease) Increase in accounts payable affiliates	(16,582)	(11,050)
Net cash (used in) provided by operating activities	(105,733)	(46,738)
Cash flows from investing activities:
Capital contributions paid to Operating Partnerships	0	0
Proceeds from the disposition of Operating Partnerships	107,131	0
Net cash (used in) provided by investing activities	107,131	0
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS	1,398	(46,738)
Cash and cash equivalents, beginning	200,227	247,141
Cash and cash equivalents, ending	201,625	200,403
Supplemental schedule of noncash investing and financing activities:
The Fund applied notes receivable and advances to its capital contribution obligation to operating limited partnerships.	0	0
Series Twenty Five
Cash flows from operating activities:
Net income (loss)	1,070,660	17,965
Adjustments to reconcile net income(loss) to net cash (used in) provided by operating activities
Amortization	0	0
Distributions from Operating Partnerships	0	0
Share of (Income) Loss from Operating Partnerships	(1,065,241)	0
Changes in assets and liabilities
(Decrease) Increase in accounts payable and accrued expenses	6,992	0
Decrease (Increase) in other assets	0	0
(Decrease) Increase in accounts payable affiliates	68,902	9,206
Net cash (used in) provided by operating activities	81,313	27,171
Cash flows from investing activities:
Capital contributions paid to Operating Partnerships	0	0
Proceeds from the disposition of Operating Partnerships	1,065,241	0
Net cash (used in) provided by investing activities	1,065,241	0
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS	1,146,554	27,171
Cash and cash equivalents, beginning	562,226	256,530
Cash and cash equivalents, ending	1,708,780	283,701
Supplemental schedule of noncash investing and financing activities:
The Fund applied notes receivable and advances to its capital contribution obligation to operating limited partnerships.	0	0
Series Twenty Six
Cash flows from operating activities:
Net income (loss)	(166,537)	(214,873)
Adjustments to reconcile net income(loss) to net cash (used in) provided by operating activities
Amortization	0	0
Distributions from Operating Partnerships	0	0
Share of (Income) Loss from Operating Partnerships	0	0
Changes in assets and liabilities
(Decrease) Increase in accounts payable and accrued expenses	(30,000)	0
Decrease (Increase) in other assets	0	0
(Decrease) Increase in accounts payable affiliates	170,208	155,722
Net cash (used in) provided by operating activities	(26,329)	(59,151)
Cash flows from investing activities:
Capital contributions paid to Operating Partnerships	0	0
Proceeds from the disposition of Operating Partnerships	0	0
Net cash (used in) provided by investing activities	0	0
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS	(26,329)	(59,151)
Cash and cash equivalents, beginning	476,868	312,412
Cash and cash equivalents, ending	450,539	253,261
Supplemental schedule of noncash investing and financing activities:
The Fund applied notes receivable and advances to its capital contribution obligation to operating limited partnerships.	0	0
Series Twenty Seven
Cash flows from operating activities:
Net income (loss)	(130,051)	(191,822)
Adjustments to reconcile net income(loss) to net cash (used in) provided by operating activities
Amortization	32,696	34,246
Distributions from Operating Partnerships	0	0
Share of (Income) Loss from Operating Partnerships	0	6,678
Changes in assets and liabilities
(Decrease) Increase in accounts payable and accrued expenses	(10,000)	0
Decrease (Increase) in other assets	0	0
(Decrease) Increase in accounts payable affiliates	62,728	107,602
Net cash (used in) provided by operating activities	(44,627)	(43,296)
Cash flows from investing activities:
Capital contributions paid to Operating Partnerships	0	0
Proceeds from the disposition of Operating Partnerships	0	0
Net cash (used in) provided by investing activities	0	0
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS	(44,627)	(43,296)
Cash and cash equivalents, beginning	550,614	273,885
Cash and cash equivalents, ending	505,987	230,589
Supplemental schedule of noncash investing and financing activities:
The Fund applied notes receivable and advances to its capital contribution obligation to operating limited partnerships.	12,841	0
Series Twenty Eight
Cash flows from operating activities:
Net income (loss)	(153,873)	(147,910)
Adjustments to reconcile net income(loss) to net cash (used in) provided by operating activities
Amortization	0	0
Distributions from Operating Partnerships	0	0
Share of (Income) Loss from Operating Partnerships	0	0
Changes in assets and liabilities
(Decrease) Increase in accounts payable and accrued expenses	0	0
Decrease (Increase) in other assets	0	0
(Decrease) Increase in accounts payable affiliates	167,058	117,058
Net cash (used in) provided by operating activities	13,185	(30,852)
Cash flows from investing activities:
Capital contributions paid to Operating Partnerships	0	0
Proceeds from the disposition of Operating Partnerships	0	0
Net cash (used in) provided by investing activities	0	0
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS	13,185	(30,852)
Cash and cash equivalents, beginning	259,714	262,507
Cash and cash equivalents, ending	272,899	231,655
Supplemental schedule of noncash investing and financing activities:
The Fund applied notes receivable and advances to its capital contribution obligation to operating limited partnerships.	0	0
Series Twenty Nine
Cash flows from operating activities:
Net income (loss)	(140,145)	(213,811)
Adjustments to reconcile net income(loss) to net cash (used in) provided by operating activities
Amortization	0	14,474
Distributions from Operating Partnerships	0	0
Share of (Income) Loss from Operating Partnerships	0	24,395
Changes in assets and liabilities
(Decrease) Increase in accounts payable and accrued expenses	0	0
Decrease (Increase) in other assets	0	0
(Decrease) Increase in accounts payable affiliates	165,702	165,702
Net cash (used in) provided by operating activities	25,557	(9,240)
Cash flows from investing activities:
Capital contributions paid to Operating Partnerships	0	0
Proceeds from the disposition of Operating Partnerships	0	0
Net cash (used in) provided by investing activities	0	0
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS	25,557	(9,240)
Cash and cash equivalents, beginning	214,315	206,375
Cash and cash equivalents, ending	239,872	197,135
Supplemental schedule of noncash investing and financing activities:
The Fund applied notes receivable and advances to its capital contribution obligation to operating limited partnerships.	0	0
Series Thirty
Cash flows from operating activities:
Net income (loss)	(100,236)	(180,874)
Adjustments to reconcile net income(loss) to net cash (used in) provided by operating activities
Amortization	0	13,138
Distributions from Operating Partnerships	0	0
Share of (Income) Loss from Operating Partnerships	0	50,800
Changes in assets and liabilities
(Decrease) Increase in accounts payable and accrued expenses	(10,000)	0
Decrease (Increase) in other assets	0	0
(Decrease) Increase in accounts payable affiliates	(12,928)	93,086
Net cash (used in) provided by operating activities	(123,164)	(23,850)
Cash flows from investing activities:
Capital contributions paid to Operating Partnerships	0	0
Proceeds from the disposition of Operating Partnerships	0	0
Net cash (used in) provided by investing activities	0	0
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS	(123,164)	(23,850)
Cash and cash equivalents, beginning	421,530	280,327
Cash and cash equivalents, ending	298,366	256,477
Supplemental schedule of noncash investing and financing activities:
The Fund applied notes receivable and advances to its capital contribution obligation to operating limited partnerships.	0	0
Series Thirty One
Cash flows from operating activities:
Net income (loss)	(188,964)	(201,711)
Adjustments to reconcile net income(loss) to net cash (used in) provided by operating activities
Amortization	0	0
Distributions from Operating Partnerships	0	0
Share of (Income) Loss from Operating Partnerships	0	0
Changes in assets and liabilities
(Decrease) Increase in accounts payable and accrued expenses	0	0
Decrease (Increase) in other assets	0	0
(Decrease) Increase in accounts payable affiliates	182,076	182,076
Net cash (used in) provided by operating activities	(6,888)	(19,635)
Cash flows from investing activities:
Capital contributions paid to Operating Partnerships	0	0
Proceeds from the disposition of Operating Partnerships	0	0
Net cash (used in) provided by investing activities	0	0
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS	(6,888)	(19,635)
Cash and cash equivalents, beginning	181,199	166,800
Cash and cash equivalents, ending	174,311	147,165
Supplemental schedule of noncash investing and financing activities:
The Fund applied notes receivable and advances to its capital contribution obligation to operating limited partnerships.	0	0
Series Thirty Two
Cash flows from operating activities:
Net income (loss)	(205,239)	(419,492)
Adjustments to reconcile net income(loss) to net cash (used in) provided by operating activities
Amortization	0	0
Distributions from Operating Partnerships	0	0
Share of (Income) Loss from Operating Partnerships	52,794	265,260
Changes in assets and liabilities
(Decrease) Increase in accounts payable and accrued expenses	0	15,000
Decrease (Increase) in other assets	0	0
(Decrease) Increase in accounts payable affiliates	141,714	146,694
Net cash (used in) provided by operating activities	(10,731)	7,462
Cash flows from investing activities:
Capital contributions paid to Operating Partnerships	0	0
Proceeds from the disposition of Operating Partnerships	0	60,000
Net cash (used in) provided by investing activities	0	60,000
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS	(10,731)	67,462
Cash and cash equivalents, beginning	495,360	340,581
Cash and cash equivalents, ending	484,629	408,043
Supplemental schedule of noncash investing and financing activities:
The Fund applied notes receivable and advances to its capital contribution obligation to operating limited partnerships.	0	0
Series Thirty Three
Cash flows from operating activities:
Net income (loss)	(84,629)	(175,973)
Adjustments to reconcile net income(loss) to net cash (used in) provided by operating activities
Amortization	0	0
Distributions from Operating Partnerships	0	0
Share of (Income) Loss from Operating Partnerships	0	90,153
Changes in assets and liabilities
(Decrease) Increase in accounts payable and accrued expenses	0	15,000
Decrease (Increase) in other assets	0	0
(Decrease) Increase in accounts payable affiliates	68,010	76,365
Net cash (used in) provided by operating activities	(16,619)	5,545
Cash flows from investing activities:
Capital contributions paid to Operating Partnerships	0	0
Proceeds from the disposition of Operating Partnerships	0	60,000
Net cash (used in) provided by investing activities	0	60,000
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS	(16,619)	65,545
Cash and cash equivalents, beginning	240,231	184,115
Cash and cash equivalents, ending	223,612	249,660
Supplemental schedule of noncash investing and financing activities:
The Fund applied notes receivable and advances to its capital contribution obligation to operating limited partnerships.	0	0
Series Thirty Four
Cash flows from operating activities:
Net income (loss)	(155,093)	(458,525)
Adjustments to reconcile net income(loss) to net cash (used in) provided by operating activities
Amortization	0	112,188
Distributions from Operating Partnerships	0	0
Share of (Income) Loss from Operating Partnerships	0	171,936
Changes in assets and liabilities
(Decrease) Increase in accounts payable and accrued expenses	0	0
Decrease (Increase) in other assets	(66,751)	0
(Decrease) Increase in accounts payable affiliates	162,873	153,018
Net cash (used in) provided by operating activities	(58,971)	(21,383)
Cash flows from investing activities:
Capital contributions paid to Operating Partnerships	0	0
Proceeds from the disposition of Operating Partnerships	0	0
Net cash (used in) provided by investing activities	0	0
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS	(58,971)	(21,383)
Cash and cash equivalents, beginning	64,486	74,138
Cash and cash equivalents, ending	5,515	52,755
Supplemental schedule of noncash investing and financing activities:
The Fund applied notes receivable and advances to its capital contribution obligation to operating limited partnerships.	0	0
Series Thirty Five
Cash flows from operating activities:
Net income (loss)	(204,582)	(461,167)
Adjustments to reconcile net income(loss) to net cash (used in) provided by operating activities
Amortization	0	36,144
Distributions from Operating Partnerships	0	0
Share of (Income) Loss from Operating Partnerships	93,491	285,533
Changes in assets and liabilities
(Decrease) Increase in accounts payable and accrued expenses	0	0
Decrease (Increase) in other assets	0	0
(Decrease) Increase in accounts payable affiliates	114,180	114,180
Net cash (used in) provided by operating activities	3,089	(25,310)
Cash flows from investing activities:
Capital contributions paid to Operating Partnerships	0	0
Proceeds from the disposition of Operating Partnerships	0	0
Net cash (used in) provided by investing activities	0	0
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS	3,089	(25,310)
Cash and cash equivalents, beginning	116,848	127,244
Cash and cash equivalents, ending	119,937	101,934
Supplemental schedule of noncash investing and financing activities:
The Fund applied notes receivable and advances to its capital contribution obligation to operating limited partnerships.	0	0
Series Thirty Six
Cash flows from operating activities:
Net income (loss)	(140,390)	(189,431)
Adjustments to reconcile net income(loss) to net cash (used in) provided by operating activities
Amortization	0	0
Distributions from Operating Partnerships	3,658	13,640
Share of (Income) Loss from Operating Partnerships	54,048	87,712
Changes in assets and liabilities
(Decrease) Increase in accounts payable and accrued expenses	0	0
Decrease (Increase) in other assets	0	0
(Decrease) Increase in accounts payable affiliates	80,298	86,322
Net cash (used in) provided by operating activities	(2,386)	(1,757)
Cash flows from investing activities:
Capital contributions paid to Operating Partnerships	0	0
Proceeds from the disposition of Operating Partnerships	0	0
Net cash (used in) provided by investing activities	0	0
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS	(2,386)	(1,757)
Cash and cash equivalents, beginning	133,266	142,855
Cash and cash equivalents, ending	130,880	141,098
Supplemental schedule of noncash investing and financing activities:
The Fund applied notes receivable and advances to its capital contribution obligation to operating limited partnerships.	0	0
Series Thirty Seven
Cash flows from operating activities:
Net income (loss)	40,599	(337,507)
Adjustments to reconcile net income(loss) to net cash (used in) provided by operating activities
Amortization	0	59,124
Distributions from Operating Partnerships	3,658	47,169
Share of (Income) Loss from Operating Partnerships	(105,414)	176,505
Changes in assets and liabilities
(Decrease) Increase in accounts payable and accrued expenses	0	0
Decrease (Increase) in other assets	0	0
(Decrease) Increase in accounts payable affiliates	102,432	102,432
Net cash (used in) provided by operating activities	41,275	47,723
Cash flows from investing activities:
Capital contributions paid to Operating Partnerships	0	0
Proceeds from the disposition of Operating Partnerships	0	0
Net cash (used in) provided by investing activities	0	0
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS	41,275	47,723
Cash and cash equivalents, beginning	346,391	309,745
Cash and cash equivalents, ending	387,666	357,468
Supplemental schedule of noncash investing and financing activities:
The Fund applied notes receivable and advances to its capital contribution obligation to operating limited partnerships.	0	0
Series Thirty Eight
Cash flows from operating activities:
Net income (loss)	(206,798)	(361,150)
Adjustments to reconcile net income(loss) to net cash (used in) provided by operating activities
Amortization	0	6,980
Distributions from Operating Partnerships	45,718	23,117
Share of (Income) Loss from Operating Partnerships	112,397	254,373
Changes in assets and liabilities
(Decrease) Increase in accounts payable and accrued expenses	0	0
Decrease (Increase) in other assets	0	0
(Decrease) Increase in accounts payable affiliates	13,009	82,200
Net cash (used in) provided by operating activities	(35,674)	5,520
Cash flows from investing activities:
Capital contributions paid to Operating Partnerships	0	0
Proceeds from the disposition of Operating Partnerships	0	0
Net cash (used in) provided by investing activities	0	0
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS	(35,674)	5,520
Cash and cash equivalents, beginning	235,617	209,324
Cash and cash equivalents, ending	199,943	214,844
Supplemental schedule of noncash investing and financing activities:
The Fund applied notes receivable and advances to its capital contribution obligation to operating limited partnerships.	0	0
Series Thirty Nine
Cash flows from operating activities:
Net income (loss)	(141,271)	(394,505)
Adjustments to reconcile net income(loss) to net cash (used in) provided by operating activities
Amortization	0	5,558
Distributions from Operating Partnerships	15,288	12,754
Share of (Income) Loss from Operating Partnerships	54,758	316,093
Changes in assets and liabilities
(Decrease) Increase in accounts payable and accrued expenses	0	0
Decrease (Increase) in other assets	0	0
(Decrease) Increase in accounts payable affiliates	68,400	68,400
Net cash (used in) provided by operating activities	(2,825)	8,300
Cash flows from investing activities:
Capital contributions paid to Operating Partnerships	0	0
Proceeds from the disposition of Operating Partnerships	0	0
Net cash (used in) provided by investing activities	0	0
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS	(2,825)	8,300
Cash and cash equivalents, beginning	187,805	183,296
Cash and cash equivalents, ending	184,980	191,596
Supplemental schedule of noncash investing and financing activities:
The Fund applied notes receivable and advances to its capital contribution obligation to operating limited partnerships.	0	0
Series Forty
Cash flows from operating activities:
Net income (loss)	(364,105)	(336,997)
Adjustments to reconcile net income(loss) to net cash (used in) provided by operating activities
Amortization	0	26,518
Distributions from Operating Partnerships	0	475
Share of (Income) Loss from Operating Partnerships	234,373	185,274
Changes in assets and liabilities
(Decrease) Increase in accounts payable and accrued expenses	0	0
Decrease (Increase) in other assets	0	0
(Decrease) Increase in accounts payable affiliates	100,008	106,223
Net cash (used in) provided by operating activities	(29,724)	(18,507)
Cash flows from investing activities:
Capital contributions paid to Operating Partnerships	0	0
Proceeds from the disposition of Operating Partnerships	0	0
Net cash (used in) provided by investing activities	0	0
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS	(29,724)	(18,507)
Cash and cash equivalents, beginning	109,745	120,514
Cash and cash equivalents, ending	80,021	102,007
Supplemental schedule of noncash investing and financing activities:
The Fund applied notes receivable and advances to its capital contribution obligation to operating limited partnerships.	0	0
Series Forty One
Cash flows from operating activities:
Net income (loss)	(528,026)	(132,446)
Adjustments to reconcile net income(loss) to net cash (used in) provided by operating activities
Amortization	76,408	111,256
Distributions from Operating Partnerships	12,141	3,026
Share of (Income) Loss from Operating Partnerships	312,104	(61,968)
Changes in assets and liabilities
(Decrease) Increase in accounts payable and accrued expenses	(8,924)	8,924
Decrease (Increase) in other assets	0	834
(Decrease) Increase in accounts payable affiliates	119,034	(179,505)
Net cash (used in) provided by operating activities	(17,263)	(249,879)
Cash flows from investing activities:
Capital contributions paid to Operating Partnerships	0	0
Proceeds from the disposition of Operating Partnerships	0	380,726
Net cash (used in) provided by investing activities	0	380,726
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS	(17,263)	130,847
Cash and cash equivalents, beginning	215,834	78,660
Cash and cash equivalents, ending	198,571	209,507
Supplemental schedule of noncash investing and financing activities:
The Fund applied notes receivable and advances to its capital contribution obligation to operating limited partnerships.	0	0
Series Forty Two
Cash flows from operating activities:
Net income (loss)	(191,022)	(199,408)
Adjustments to reconcile net income(loss) to net cash (used in) provided by operating activities
Amortization	35,858	49,692
Distributions from Operating Partnerships	36,550	150
Share of (Income) Loss from Operating Partnerships	33,353	95,877
Changes in assets and liabilities
(Decrease) Increase in accounts payable and accrued expenses	0	0
Decrease (Increase) in other assets	0	0
(Decrease) Increase in accounts payable affiliates	124,890	124,890
Net cash (used in) provided by operating activities	39,629	71,201
Cash flows from investing activities:
Capital contributions paid to Operating Partnerships	0	(100,361)
Proceeds from the disposition of Operating Partnerships	0	0
Net cash (used in) provided by investing activities	0	(100,361)
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS	39,629	(29,160)
Cash and cash equivalents, beginning	311,423	348,800
Cash and cash equivalents, ending	351,052	319,640
Supplemental schedule of noncash investing and financing activities:
The Fund applied notes receivable and advances to its capital contribution obligation to operating limited partnerships.	0	182,999
Series Forty Three
Cash flows from operating activities:
Net income (loss)	(468,656)	(390,142)
Adjustments to reconcile net income(loss) to net cash (used in) provided by operating activities
Amortization	49,458	123,874
Distributions from Operating Partnerships	64,812	1,368
Share of (Income) Loss from Operating Partnerships	255,518	180,726
Changes in assets and liabilities
(Decrease) Increase in accounts payable and accrued expenses	0	0
Decrease (Increase) in other assets	0	(85,806)
(Decrease) Increase in accounts payable affiliates	101,908	153,390
Net cash (used in) provided by operating activities	3,040	(16,590)
Cash flows from investing activities:
Capital contributions paid to Operating Partnerships	0	0
Proceeds from the disposition of Operating Partnerships	0	0
Net cash (used in) provided by investing activities	0	0
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS	3,040	(16,590)
Cash and cash equivalents, beginning	234,982	256,265
Cash and cash equivalents, ending	238,022	239,675
Supplemental schedule of noncash investing and financing activities:
The Fund applied notes receivable and advances to its capital contribution obligation to operating limited partnerships.	0	186,626
Series Forty Four
Cash flows from operating activities:
Net income (loss)	(649,235)	(716,896)
Adjustments to reconcile net income(loss) to net cash (used in) provided by operating activities
Amortization	141,400	141,991
Distributions from Operating Partnerships	0	5,728
Share of (Income) Loss from Operating Partnerships	401,391	424,271
Changes in assets and liabilities
(Decrease) Increase in accounts payable and accrued expenses	0	0
Decrease (Increase) in other assets	0	(104,834)
(Decrease) Increase in accounts payable affiliates	142,352	142,352
Net cash (used in) provided by operating activities	35,908	(107,388)
Cash flows from investing activities:
Capital contributions paid to Operating Partnerships	0	0
Proceeds from the disposition of Operating Partnerships	0	0
Net cash (used in) provided by investing activities	0	0
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS	35,908	(107,388)
Cash and cash equivalents, beginning	395,938	590,586
Cash and cash equivalents, ending	431,846	483,198
Supplemental schedule of noncash investing and financing activities:
The Fund applied notes receivable and advances to its capital contribution obligation to operating limited partnerships.	0	0
Series Forty Five
Cash flows from operating activities:
Net income (loss)	(727,997)	(979,727)
Adjustments to reconcile net income(loss) to net cash (used in) provided by operating activities
Amortization	136,546	136,546
Distributions from Operating Partnerships	39,205	22,376
Share of (Income) Loss from Operating Partnerships	392,636	624,715
Changes in assets and liabilities
(Decrease) Increase in accounts payable and accrued expenses	0	0
Decrease (Increase) in other assets	0	0
(Decrease) Increase in accounts payable affiliates	183,282	83,282
Net cash (used in) provided by operating activities	23,672	(112,808)
Cash flows from investing activities:
Capital contributions paid to Operating Partnerships	0	0
Proceeds from the disposition of Operating Partnerships	0	0
Net cash (used in) provided by investing activities	0	0
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS	23,672	(112,808)
Cash and cash equivalents, beginning	425,893	537,189
Cash and cash equivalents, ending	449,565	424,381
Supplemental schedule of noncash investing and financing activities:
The Fund applied notes receivable and advances to its capital contribution obligation to operating limited partnerships.	0	0
Series Forty Six
Cash flows from operating activities:
Net income (loss)	(474,095)	(610,712)
Adjustments to reconcile net income(loss) to net cash (used in) provided by operating activities
Amortization	15,902	21,448
Distributions from Operating Partnerships	3,948	3,222
Share of (Income) Loss from Operating Partnerships	305,935	442,567
Changes in assets and liabilities
(Decrease) Increase in accounts payable and accrued expenses	0	0
Decrease (Increase) in other assets	0	0
(Decrease) Increase in accounts payable affiliates	124,764	124,764
Net cash (used in) provided by operating activities	(23,546)	(18,711)
Cash flows from investing activities:
Capital contributions paid to Operating Partnerships	0	(11,223)
Proceeds from the disposition of Operating Partnerships	0	0
Net cash (used in) provided by investing activities	0	(11,223)
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS	(23,546)	(29,934)
Cash and cash equivalents, beginning	291,568	267,639
Cash and cash equivalents, ending	268,022	237,705
Supplemental schedule of noncash investing and financing activities:
The Fund applied notes receivable and advances to its capital contribution obligation to operating limited partnerships.	$ 0	$ 0